March 17, 2020
Clinical microbiology experts at UNC’s Medical Center and School of Medicine have developed a coronavirus disease diagnostic test based on the World Health Organization protocol. It is now in use to conduct COVID-19 testing for...Read More
March 13, 2020
Ralph Baric was finishing his postdoctoral work in microbiology in the early 1980s just as the HIV epidemic was emerging. That might have been a logical direction for his research, but something else caught his...Read More
UNC researchers will use an $11.3 million grant to explore using nanoparticles to create cancer vaccines and improve delivery of cancer-fighting drugs and patients’ responses to them.
The five-year grant announced Monday is the third in a series of awards that the University has won from the National Cancer Institute for cancer nanotechnology research. It will fund researchers with the Carolina Center of Cancer Nanotechnology Excellence, an institute-funded collaboration between the University and the UNC Lineberger Comprehensive Cancer Center.
“UNC-Chapel Hill has emerged as a leader in nanotechnology in the last 10 years,” said Leaf Huang, a UNC Lineberger member, Fred Eshelman Distinguished Professor and interim chair of the UNC Eshelman School of Pharmacy Division of Molecular Therapeutics, and the co-leader of the cancer nanotechnology center. “This grant is a testament to the quality of our research in using nanotechnology to continue to find innovative ways to fight cancer.”
The grant will fund four studies of nanotechnology in fighting cancer: